Investigation Research
Investigation of Chinese residency training program of radiation oncology
Yang Yuexin, Zhou Jiaomei, Zhang Ye, Liang Jun, Chen Zhijian, Jin Jing
Published 2022-09-15
Cite as Chin J Radiat Oncol, 2022, 31(9): 772-777. DOI: 10.3760/cma.j.cn113030-20210726-00270
Abstract
ObjectiveTo evaluate the compliance with Chinese Residency Training Program of radiation oncology and provide reference for the improvement of system reform and base construction.
MethodsAn survey was conducted among residents who had completed residency training program of radiation oncology by online questionnaires in four dimensions, including the fulfillment of training center in hardware, personnel and procedures, the compliance with syllabuses, mechanism of trainee evaluation, and the passing rate and satisfaction degree of trainees.
ResultsThe results showed that most training centers fulfilled the requirement of equipment, mentoring personnel and procedures. The training syllabuses had been followed and integrated with organization multi-modalities. The trainees with high degree of satisfaction accounted for 65.6%, and the final qualification passing rate reached 75.5%. However, there were less reference textbooks, insufficient training in general medicine, limited clinical practice, and low output in academic publication.
ConclusionsThe residency training program of radiation oncology has been established in China and achieved notable progress. For the further improvement, quantitative optimization of procedures, increasing opportunity of practice and strengthening scientific research involvement would be beneficial.
Key words:
Radiation oncology; Residency training program; Compliance
Contributor Information
Yang Yuexin
Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer /Cancer Hospital &
Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China
Zhou Jiaomei
Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer /Cancer Hospital &
Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China
Zhang Ye
Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Liang Jun
Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer /Cancer Hospital &
Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China
Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Chen Zhijian
Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer /Cancer Hospital &
Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China
Jin Jing
Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer /Cancer Hospital &
Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, China
Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
